Artelo Biosciences Inc (ARTL)

Artelo Biosciences Inc (ARTL) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.4M; returns 1 day +0.0%, 1 week -5.6%, 1 year -97.2%.

Artelo Biosciences Inc. (ARTL) is a clinical-stage biopharmaceutical company dedicated to developing novel therapeutics that modulate lipid-signaling pathways to address significant unmet medical needs.

Groups ARTL belongs to

• Recent Reverse Splits
• Biotechnology
• Clinical Stage Biotech
• Biopharmaceutical
• Pharmaceuticals
• Clinical Stage
• Healthcare
• Unmet Medical Needs
• Oncology

ARTL financial model: income statement, cash flow and balance sheet